Did Big Pharma BUY Big Media?
Healthcare is at the top of the list of societal problems in the U.S. Healthcare interactions are unsatisfying to most people, costs are out of control and cost every American nearly $10,000 per person per year while bleeding 17.5% of GDP, more than any other nation on earth for a system that ranks low or last in quality compared to other developed countries. For a problem as big as healthcare, big enough to cripple the entire economy in addition to bankrupting more and more Americans, you would think that media reporting would be filled with debate, criticisms, and in-depth coverage about the problems in healthcare. But there is something peculiar going on: Despite the enormity of the problems surrounding healthcare, there are virtually no nationally broadcast analyses of the problems in healthcare. Yes, there is debate about how Trump’s new healthcare plan will replace or modify Obamacare–the politics of healthcare. But glaringly absent from Big Media discussions is any substantive talk about the costs of prescription drugs, biologic agents that cost several thousand dollars per month, skyrocketing hospital charges, the impenetrable world of medical billing, out-of-control costs for medical devices, research showing that the more money spent on healthcare the higher the mortality, and other issues. Watch ABC’s Good Morning America and you will not hear much discussion about the costs of prescription drugs. Watch NBC’s Today Show and you will he...
Publication date: August 2020Source: Journal of Functional Foods, Volume 71Author(s): Mohammad Zeinali Khosroshahi, Omid Asbaghi, Sajjad Moradi, Mahnaz Rezaei kelishadi, Mojtaba Kaviani, Mahnaz Mardani, Cyrus Jalili
Publication date: Available online 30 May 2020Source: Brain, Behavior, and ImmunityAuthor(s): Julie Lasselin, Sven Benson, Johannes Hebebrand, Karoline Boy, Vera Weskamp, Analena Handke, Till Hasenberg, Miriam Remy, Manuel Föcker, Meike Unteroberdörster, Alexandra Brinkhoff, Harald Engler, Manfred Schedlowski
Publication date: Available online 30 May 2020Source: Journal of the Formosan Medical AssociationAuthor(s): Jia-Kang Wang, Tzu-Lun Huang, Pei-Yao Chang
Publication date: Available online 30 May 2020Source: Molecular MetabolismAuthor(s): Veronika Leiss, Annika Schönsiegel, Thorsten Gnad, Johannes Kerner, Jyotsna Kaur, Tina Sartorius, Jürgen Machann, Fritz Schick, Lutz Birnbaumer, Hans-Ulrich Häring, Alexander Pfeifer, Bernd Nürnberg
Publication date: Available online 30 May 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Hema S. Gopalan, Anoop Misra
Publication date: Available online 30 May 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Sachin Atre, Sona Deshmukh, Manjusha Kulkarni
Publication date: 15 September 2020Source: Journal of Ethnopharmacology, Volume 259Author(s): Junnan Ma, Xianglong Meng, Yi Liu, Cheng Yin, Tong Zhang, Piao Wang, Yong-Ki Park, Hyo Won Jung
Publication date: August 2020Source: Biomedicine &Pharmacotherapy, Volume 128Author(s): Tian-Tian Liu, Xiao-Tian Liu, Qing-Xi Chen, Yan Shi
Osborne H Abstract The calcium-sensing receptor (CaSR) is a class C G protein-coupled receptor that responds to multiple endogenous agonists and allosteric modulators, including divalent and trivalent cations, L-amino acids, γ-glutamyl peptides, polyamines, polycationic peptides, and protons. The CaSR plays a critical role in extracellular calcium (Ca2+ o) homeostasis, as demonstrated by the many naturally occurring mutations in the CaSR or its signaling partners that cause Ca2+ o homeostasis disorders. However, CaSR tissue expression in mammals is broad and includes tissues unrelated to Ca2+ o homeostasis, ...
Publication date: July 2020Source: American Heart Journal, Volume 225Author(s): Angela Lowenstern, Shuang Li, Salim S. Virani, Ann Marie Navar, Zhuokai Li, Jennifer G. Robinson, Veronique L. Roger, Anne C. Goldberg, Andrew Koren, Michael J. Louie, Eric D. Peterson, Tracy Y. Wang
More News: Aciphex | Advertising | American Health | AstraZeneca | Bleeding | Blogging | Boniva | Cardiology | Cialis | Dexilant | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Economy | Enbrel | Endocrinology | Esomeprazole | Eyes | Heart | Hepatitis | Hepatitis C | Hospitals | Humira | Lansoprazole | Lovaza | Lyrica | Medical Billing | Medical Devices | Myeloma | Nexium | Nutrition | Obesity | Omeprazole | Pantoprazole | Pharmaceuticals | Politics | Prevacid | Prilosec | Protonix